Broadspectrum Pharmaceuticals Private Limited
About Broadspectrum Pharmaceuticals Private Limited
Data last updated:
Broadspectrum Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 03 January 2017.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2017PTC310094. Its GSTIN is 09AAHCB0275C1ZZ (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sarika Rai and Rajnish Kant Rai.
Its last annual general meeting (AGM) was held on 25 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at H. No.52 Flant No. 9 Blk – 1 2nd Floor Gulab Bagh Uttam Nagar Near Gupta Asso, Ciates, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2018, the company reported a revenue of ₹32,164. For the same year it recorded a net profit of ₹1,746 (net margin 5.4%) and EBITDA of ₹2,366 (EBITDA margin 7.4%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH. No.52 Flant No. 9 Blk – 1 2nd Floor Gulab Bagh Uttam Nagar Near Gupta Asso, Ciates, New Delhi, Delhi, India – 110059
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Broadspectrum Pharmaceuticals Private Limited FY 2021 filings available
Broadspectrum Pharmaceuticals Private Limited reported revenue of ₹32,164 for FY 2018.
Financial Statement Summary of Broadspectrum Pharmaceuticals Private Limited
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹2,366 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹1,746 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Broadspectrum Pharmaceuticals Private Limited
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 7.4% | •••• |
| Net Profit Margin | 5.4% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Broadspectrum Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Broadspectrum Pharmaceuticals Private Limited
Broadspectrum Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarika Rai | Director | 03 Jan 2017 | 9 Years 9 Months | Current |
| Rajnish Kant Rai | Director | 03 Jan 2017 | 9 Years 9 Months | Current |
Peer Comparison of Broadspectrum Pharmaceuticals Private Limited
Broadspectrum Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asara Medi Pharmaceuticals Private Limited | ₹33,034 (FY 2018) | •••• | •••• | 24.0% | •••• | Agra, Uttar Pradesh, India |
| Prayansh Pharmaceuticals Private Limited | ₹32,589 (FY 2020) | •••• | •••• | -96.0% | •••• | Jhansi, Uttar Pradesh, India |
| Image Pharmaceuticals Private Limited | ₹32,514 (FY 2021) | •••• | •••• | -61.0% | •••• | Anand, Gujarat, India |
| Assam Surgical and Pharmaceuticals Pvt Ltd | ₹32,300 (FY 2016) | •••• | •••• | 10.0% | •••• | Guwahati, Assam, India |
| Seamens Pharmaceuticals Pvt.Ltd. | ₹32,180 (FY 2025) | •••• | •••• | -21.0% | •••• | Kanpur, Uttar Pradesh, India |
| Broadspectrum Pharmaceuticals Private Limited this company | ₹32,164 (FY 2018) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Papez Pharmaceuticals Private Limited | ₹31,856 (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Deepvin Pharmaceuticals Private Limited | ₹31,729 (FY 2024) | •••• | •••• | -82.0% | •••• | Lucknow, Uttar Pradesh, India |
| Neopower Pharmaceuticals Private Limited | ₹31,100 (FY 2024) | •••• | •••• | -93.0% | •••• | Hazaribagh, Jharkhand, India |
| Baldwin Pharmaceuticals Private Limited | ₹31,063 (FY 2022) | •••• | •••• | -58.0% | •••• | Jammu, Jammu and Kashmir, India |
| Kingbuild Pharmaceuticals Private Limited | ₹30,800 (FY 2021) | •••• | •••• | -52.0% | •••• | Surat, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Broadspectrum Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Broadspectrum Pharmaceuticals Private Limited
Broadspectrum Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Broadspectrum Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Broadspectrum Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Broadspectrum Pharmaceuticals Private Limited
Broadspectrum Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Rajnish Kant Rai was appointed as Director on 03 Jan 2017.
Credit Ratings, Litigation & Regulatory Alerts for Broadspectrum Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Broadspectrum Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Broadspectrum Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Broadspectrum Pharmaceuticals Private Limited
Broadspectrum Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCB0275C1ZZ | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Broadspectrum Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Broadspectrum Pharmaceuticals Private Limited
Broadspectrum Pharmaceuticals is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Broadspectrum Pharmaceuticals is a company pending strike off, currently registered as a private limited company based in New Delhi, Delhi, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 03 January 2017 and is registered under CIN U24304DL2017PTC310094. The company may be struck off soon - caution is advised.
The compliance status of Broadspectrum Pharmaceuticals is compliant as of 26 September 2026.
Broadspectrum Pharmaceuticals has 2 current directors:
- Sarika Rai - Director
- Rajnish Kant Rai - Director
The CIN (Corporate Identification Number) of Broadspectrum Pharmaceuticals is U24304DL2017PTC310094. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Broadspectrum Pharmaceuticals was incorporated on 03 January 2017. It is registered with the Registrar of Companies, Delhi.
The registered office of Broadspectrum Pharmaceuticals is at H. No.52 Flant No. 9 Blk – 1 2nd Floor Gulab Bagh Uttam Nagar Near Gupta Asso, Ciates, New Delhi, Delhi, India – 110059.
Broadspectrum Pharmaceuticals reported revenue of ₹32,164 for FY 2018.
Broadspectrum Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Broadspectrum Pharmaceuticals reported a net profit of ₹1,746 (net margin 5.4%) and EBITDA of ₹2,366 (EBITDA margin 7.4%) for FY 2018, as per its filed financial statements.
The GSTIN of Broadspectrum Pharmaceuticals is 09AAHCB0275C1ZZ, registered in Uttar Pradesh.